Satellite Symposia
The Academy of Managed Care Pharmacy (AMCP) as a courtesy provides the following listing to you; these non-commercial industry-supported Satellite Symposia activities are not part of the AMCP Annual Meeting 2018 educational programming, but they are an important part of our meeting and are planned to meet the same standards of continuing quality education. Satellite Symposia offer continuing pharmacy education (CPE) credit—some also offer continuing medical education (CME) credit, continuing nursing education (CNE) credit, or all three. Satellite Symposia in conjunction with the AMCP Annual Meeting 2018 are held at the Boston Convention & Exhibition Center in Boston, Massachusetts. Any pre-registration taken for these activities is for planning purposes only and does not guarantee a seat. Seating is limited and provided on a first-come, first-served basis. An early arrival is recommended. For additional information about a specific symposium please contact the program manager listed.
Monday, April 23, 2018 | 6:00 pm – 8:00 pm
SS01: Managing Multiple Sclerosis: Current Treatment and Care Management Strategies for Managed Care
Provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Supported by independent educational grants from Celgene Corporation and Sanofi-Genzyme.
Continuing education credit available for pharmacists and physicians.
Program Description
Multiple sclerosis (MS) is a complex disease that requires a collaborative approach to care to achieve optimal patient care and outcomes. Disease-modifying therapies (DMTs) are a core component of MS management. Due to a lack of head-to-head trials, it is difficult to determine which therapy would be most effective for MS; however, it is possible to evaluate current therapies based on their effects on sustained disability, relapse rate, lesion load, brain atrophy, and cognitive dysfunction. Members of the clinical team, as well as patients, need to coordinate these efforts when choosing the appropriate therapy and continually monitor the disease while managing symptoms and the psychological aspects of the disease. Therefore, it is important for specialty pharmacists and other managed care professionals to be aware of and engaged in the care and treatment of patients with MS.
The activity will consist of three expert faculty demonstrating the unique value each brings to the overall care of patients through real world examples and case studies. By working together via data sharing and collaboration between payers, clinicians, specialty pharmacy, and patients, on a more integrated approach, current barriers will be overcome, demonstrating value to all parties and motivating them to become further engaged.
Program Manager
Steven Casebeer, MBA
Impact Education, LLC
info@impactedu.net
215-619-8812, extension 102
No Fee Registration: Click Here
Tuesday, April 24, 2018 | 6:00 am – 8:00 am
SS02: An American Journal of Managed Care® Symposium: Examining the Impact of Extended Half-Life Clotting Factors to the Managed Care Setting—Featuring a Patient Perspective
Provided by Pharmacy Times Continuing Education™
Supported by an independent educational grant from Shire.
Continuing education credit available for pharmacists.
Program Description
With the advancements in hemophilia therapy, managed care providers need to be aware of the quality of life and economic considerations of treatment options to provide the care required by patients with hemophilia. This activity will feature an interactive discussion among a hematologist, a clinical pharmacist, and a managed care pharmacist on the role of extended half-life products in hemophilia treatment as it relates to managed care. The panel will also respond to a recorded interview of a patient with hemophilia, who will describe their experiences and challenges living with hemophilia and accessing treatment.
Program Manager
Nicole Grassano
Pharmacy Times Continuing Education™
ngrassano@pharmacytimes.com
1-800-597-6372
No Fee Registration: Click Here
Tuesday, April 24, 2018 | 6:00 am – 8:00 am
SS03: Preventing Frequent Asthma Attacks: Proven Strategies and State-of-the-Art Treatments for Optimal Managed Care Decision-Making
Provided by PRIME Education, LLC.
Supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Continuing education credit available for pharmacists, physicians, nurses and case managers.
Program Description
This thought-provoking symposium aims to address the multifaceted challenges faced by managed care and specialty pharmacy professionals as they strive to keep abreast of the rapidly changing landscape of asthma treatment and improve patient outcomes while containing escalating treatment costs.
Through challenging case-based scenarios, expert faculty will engage the audience in applying the latest clinical evidence to managed care decision-making within their organizations. The evidence and expert perspectives presented in this program will assist participants in decisions related to patient selection, benefit designs, and medication therapy management.
Top 5 Reasons to Attend:
- Get hot-off-the-press evidence from key conferences, including the AAAAI/WAO Joint Congress
- Hear expert views from renowned asthma and specialty pharmacy faculty
- Problem-solve and apply what you’ve learned by making decisions in complex patient scenarios involving persistent asthma and comorbidities
- Ask the experts your most pressing questions
- Learn tips and strategies for aligning your organization with evolving evidence
Program Manager:
Samantha Hoffman
PRIME Education, LLC
s.hoffman@primeinc.org
(954) 718-6055
No Fee Registration: Click Here
Wednesday, April 25, 2018 | 6:00 am – 8:00 am
SS04: The Management of Atopic Dermatitis: Entering a New Paradigm
Provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Supported by independent educational grants from Sanofi Genzyme and Regeneron Pharmaceuticals.
Continuing education credit available for pharmacists and physicians.
Program Description
Atopic dermatitis (AD), or eczema, is a complex, chronic, relapsing inflammatory skin disease marked by pruritus and skin irritation. Recent studies have documented the adverse effects of AD on mental health and quality of life and new evidence suggests a relationship between AD and other chronic, nonallergic conditions including obesity, cardiovascular disease, autoimmunity, and malignancies. This symposium is focused on AD diagnosis and treatment, impact of emerging therapies, adherence to therapy, and management of the pharmacy benefit. It is specifically designed to meet the needs of health care decision makers (HCDMs) from health plans, insurers, health systems, and other payers responsible for the benefit management, therapeutic category review, and AD clinical pathway development.
Program Manager
Steven Casebeer, MBA
Impact Education, LLC
info@impactedu.net
215-619-8812, extension 102
No Fee Registration: Click Here
Wednesday, April 25, 2018 | 6:00 am – 8:00 am
SS05: Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC: A Primer for Managed Care Pharmacy
Provided by Clinical Care Options and Postgraduate Institute for Medicine.
Supported by an independent educational grant from AstraZeneca.
Continuing education credit available for pharmacists and physicians.
Program Description
Recent data have expanded treatment options for unresectable stage III non-small-cell lung cancer (NSCLC). With the evolution in the use of immunotherapy for stage III NSCLC, managed care pharmacy professionals will benefit from expert perspectives on these data and how they should be integrated into care plans for their patients with early-stage disease.
Participants in this interactive, CE-certified symposium can expect to achieve an increased awareness and competency in applying this new treatment paradigm into practice. Both oncology and managed care experts will review the underlying rationale and the latest clinical data for immune checkpoint inhibitor therapy for patients with unresectable stage III NSCLC. The program faculty will also provide practical guidance on the following:
- Integrating cancer immunotherapies into stage III treatment plans
- Identification of patients most likely to benefit from immunotherapy
- Identification and optimal management of immune-related adverse events
- Patient education, consultation, and collaboration strategies
Program Manager
Eleanor Gallelli
egallelli@clinicaloptions.com
CCO Registration Desk
registration@clinicaloptions.com
For help with registering, call 1-855-224-2241
(9:00 AM – 5:00 PM Eastern, weekdays)
No Fee Registration: Click Here
Wednesday, April 25, 2018 | 6:00 pm – 8:00 pm
SS06: Town Hall: Redefining Value Propositions and Managed Care Considerations in Multiple Myeloma
Provided by PRIME Education, LLC
Supported by an independent educational grant from AbbVie, Inc.
Continuing education credit available for pharmacists, physicians and nurses.
Program Description:
This town hall-style meeting provides an open forum to share and discuss the challenges you have faced in optimizing outcomes for patients with multiple myeloma (MM) across several lines of therapy. Join an expert faculty panel in dialogue on risk-stratified approaches, including how to integrate the latest clinical evidence, guidelines, and response monitoring into re-treatment decisions while containing lifetime treatment costs. Interpret the latest real-world data on MM treatment usage, analyze the long-term impact on patients and systems, and consider the value-based implications of sequencing combination regimens through the lens of managed care professionals.
Top 5 Reasons to Attend:
- Open forum to ask experts your most pressing case questions
- Apply risk-adapted strategies in treatment decisions for complex patient cases
- Renowned experts hear your challenges and provide evidence-based insights
- Discuss impact analyses and clinical evidence from key conferences, including ASH and ASCO
- Learn tips and strategies for aligning your organization with best-practices informed by evolving evidence
Program Manager:
Samantha Hoffman
PRIME Education, LLC
s.hoffman@primeinc.org
(954) 718-6055
No Fee Registration: Click Here
Wednesday, April 25, 2018 | 6:00 pm – 8:00 pm
SS07: Meeting the Challenge of Psoriatic Disease: Optimal Care and Cost Management Strategies for Managed Care
Provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Supported by independent educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.
Continuing education credit available for pharmacists and physicians.
Program Description
Psoriasis is one of the most common autoimmune diseases to develop in genetically susceptible individuals with an estimated 7.5 million Americans afflicted by psoriasis; and psoriatic arthritis is considered to be one of the most disabling types of arthritis affecting as many as 2.3 million Americans. As novel agents become available, treatment decision making is becoming more complex and managed care professionals need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. The expert faculty panel will present the latest clinical data to recommend appropriate therapies, utilize care pathways, design appropriate medical and pharmacy benefits, and implement health care quality measures.
Program Manager
Steven Casebeer, MBA
Impact Education, LLC
info@impactedu.net
215-619-8812, extension 102
No Fee Registration: Click Here
Thursday, April 26, 2018| 6:00 am – 7:45 am
SS08: An American Journal of Managed Care® Symposium: Understanding the Role of New and Emerging Agents to Treat Migraine Headaches—Featuring a Patient Perspective
Provided by Pharmacy Times Continuing Education™
Supported by independent educational grants from Lilly and Amgen.
Continuing education credit available for pharmacists.
Program Description
As biologics for treating migraine approach approval, managed care decision makers need to understand that these agents will not be like the small-molecule drugs used currently. This activity, featuring a faculty panel consisting of a headache specialist, a clinical pharmacist, and a managed care pharmacist, will examine the current and changing migraine treatment landscape. Included in the discussion will be highlights from a patient interview where a migraineur will detail the real-world impact of living with this debilitating disease.
Program Manager
Nicole Grassano
Pharmacy Times Continuing Education™
ngrassano@pharmacytimes.com
1-800-597-6372
No Fee Registration: Click Here
Thursday, April 26, 2018| 6:00 am – 7:45 am
SS09: Hemophilia Treatment Recommendations and Cost Management for Managed Care and Specialty Pharmacy
Provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Supported by independent educational grants from Novo Nordisk, Inc., CSL Behring, and Shire.
Continuing education credit available for pharmacists and physicians.
Program Description
Hemophilia is a high cost chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes require a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans, and employers in meeting clinical and/or financial goals. This symposium features a Specialty Pharmacy Expert and a leading Hematologist.
The program will provide an advanced clinical update and emphasize the need for well-coordinated treatment management, best practices to integrate hemophilia care with payer policies, and the value of having collaboration among all stakeholders. It is designed to engage the faculty and audience to develop solutions for specialty pharmacy professionals to implement within their own setting to improve outcomes for patients with hemophilia.
Program Manager
Steve Casebeer, MBA
Impact Education, LLC
info@impactedu.net
215-619-8812, extension 102
No Fee Registration: Click Here